Emmvee Photovoltaic Power Ltd

- The company has secured a loan sanction of INR 3,306 crore from IREDA for its 6 GW integrated cell and module facility project at ITIR Phase 2 in Bangalore. - This debt will come in a phased manner, with full capitalization expected by April 2027 (FY 2028 financial year). - The company aims to maintain a debt-to-equity ratio of less than one during this expansion. - With strong results and cash flow, the company may not draw the full loan amount and expects to fund part of the capacity expansion through internal accruals. - Post-IPO, the company has repaid INR 1,621 crore of long-term debt, strengthening the balance sheet and reducing interest costs. - No specific mention of new equity fundraising has been made in the provided transcript; focus remains on debt funding and internal accruals for expansion.

- Emmvee is expanding its capacity with a new 6 GW integrated cell and module manufacturing facility at ITIR Phase 2, Bangalore. - Capex outlook for the 6 GW TopCon integrated facility is about INR 5,500 crore. - The 6 GW cell expansion is greenfield and expected to be fully operational by March-April 2027. - An additional 2.5 GW module line will come online in FY 2026, supporting scale-up. - The company secured a loan sanction of INR 3,306 crore from IREDA for the 6 GW project. - Emmvee continues to invest in advanced technologies, automation, digitization, and SAP-driven control systems. - Capital allocation focuses on quality-driven expansion, moderate sustainable growth, and strengthening backward integration.

- Emmvee’s revenue growth is driven by capacity expansions; current installed capacity is 7.8 GW of modules and 2.94 GW of cells. - Confirmed order book of over 5 GW provides visibility for the next 12 to 18 months, aligned with planned capacity growth. - New 6 GW integrated cell and module facility at ITIR Phase 2 in Bangalore is underway; expected operational by March-April 2027, expanding capacity significantly. - Company plans to maintain order book size roughly equivalent to 12-18 months of work capacity, growing in line with capacity expansions. - Revenue potential seen from current 7.8 GW capacity is around ₹2191 crore in H1 FY26, indicating strong scale-up prospects. - Expansion is backed by a strong balance sheet after repaying ₹1621 crore of debt via IPO proceeds. - Demand momentum is robust, including from rooftop solar and round-the-clock installations, supporting future sales growth.

- Emmvee projects continued strong growth aligned with capacity expansions; current capacity stands at 7.8 GW modules and 2.94 GW cells, with a confirmed order book of 5 GW covering 12-18 months. - Revenue growth driven by higher module volumes and backward integration into cell manufacturing; H1 FY26 revenue increased 193% YoY to ₹2,159 crore. - EBITDA margins maintained robustly around 30-35%, supported by higher utilization, integration benefits, and cost efficiencies. - Reduction of long-term debt post-IPO repayment of ₹1,621 crore strengthens the balance sheet and reduces interest expenses by ₹35-40 crore per quarter, improving profitability. - New 6 GW integrated cell and module facility expected operational by March/April 2027, further expanding capacity and margins. - Management aims to sustain EBITDA margins around current levels while scaling operations and investing in technology and backward integration. - Overall, expect consistent earnings growth, stable margins, and improved EPS driven by capacity ramp-up, cost optimization, and leverage reduction.

- Current confirmed order book stands at over 5 gigawatts (GW). - Of this, approximately 20% are Domestic Content Requirement (DCR) orders. - Order book provides clear visibility for the next 12 to 18 months of deliveries. - Orders are primarily fixed price contracts with advance payments for raw material procurement. - Order book grows in line with the company's capacity expansion to maintain a steady 12 to 18 months delivery pipeline. - The company does not take orders that significantly exceed its capacity, ensuring manageable order fulfillment. - Expansion programs include adding new module and cell manufacturing capacities, supporting future order book growth. - There is a robust pipeline of tenders applied for, with execution timelines typically 12 to 18 months after order confirmation.